Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Ramasamy and Agarwal, 2008)
Other research highlights: 30% of GLP-1 users tested positive for SIBO or IMO even after accounting for diabetes (5) GLP-1 medicines caused microbiome changes and altered metabolism in mice (6) GLP-1 medicines tested in humans only had noticeable microbiome changes by 48 weeks (7) Despite not necessarily having slower gut motility, one study found that 88.9% of obese patients had SIBO (8) A meta analysis of people with IBS symptoms, found that up to 78% of people had SIBO, many of whom were undiagnosed (9) Overall, Sun and colleagues (1) could not prove a mechanistic link between GLP-1 medications and SIBO, however they did find that SIBO was twice as likely in GLP-1 users
Topical effects are usually mild and local: redness, tingling, dryness, or transient irritation, more common above 4% concentration
Injectable (fitness use): commonly 200500 mg per injection, 25 times per week
US$ 21.98
US$ 28.51
US$ 23.86
US$ 27.09
US$ 25.13
